Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Siemens Healthineers AG grew revenues 3.15% from 21.68bn to 22.36bn. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 28.69% net income growth from 1.51bn to 1.94bn.
Gross margin37.87%
Net profit margin8.76%
Operating margin12.55%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in EURView more

In 2024, Siemens Healthineers AG increased its cash reserves by 19.40%, or 436.00m. The company earned 2.83bn from its operations for a Cash Flow Margin of 12.64%. In addition the company used 666.00m on investing activities and also paid 1.66bn in financing cash flows.
Cash flow per share2.84
Price/Cash flow per share17.74
Book value per share--
Tangible book value per share--
More ▼

Balance sheet in EURView more

Siemens Healthineers AG uses little or no debt in its capital structure.
Current ratio--
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in EUR

SmartText is unavailable
EPS growth(5 years)2.00
EPS (TTM) vs
TTM 1 year ago
28.97
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.